A. Berger , C. Matei , P. Lallemant , P. Guiot , N. Bischoff , X. Delabranche
{"title":"Phase contact dans la réponse hémostatique et vasculaire vers un système intégré","authors":"A. Berger , C. Matei , P. Lallemant , P. Guiot , N. Bischoff , X. Delabranche","doi":"10.1016/S1297-9562(06)80010-0","DOIUrl":null,"url":null,"abstract":"<div><p>Contact system was thought to be an accessory pathway for thrombin generation. It appears that this system participate to fibrinolysis, vascular tone and capillary permeability regulation. These actions are mediated by FXII and bradykinin generated from high molecular weight kininogen. C1-inhibitor is the main regulatory protein. During cardiopulmonary bypass, activation of contact system occurs with secondary fibrinolysis, capillary leak syndrome and vasopl6gie. CI-inhibitor consumption leads to acquired deficit and therapeutic use may be of interest.</p></div>","PeriodicalId":100733,"journal":{"name":"ITBM-RBM","volume":"27 ","pages":"Pages S31-S34"},"PeriodicalIF":0.0000,"publicationDate":"2006-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1297-9562(06)80010-0","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ITBM-RBM","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1297956206800100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Contact system was thought to be an accessory pathway for thrombin generation. It appears that this system participate to fibrinolysis, vascular tone and capillary permeability regulation. These actions are mediated by FXII and bradykinin generated from high molecular weight kininogen. C1-inhibitor is the main regulatory protein. During cardiopulmonary bypass, activation of contact system occurs with secondary fibrinolysis, capillary leak syndrome and vasopl6gie. CI-inhibitor consumption leads to acquired deficit and therapeutic use may be of interest.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
